The Lyme Wars: time to listen

Bibliography

• STEERE AC, TAYLOR E, MCHUGH GL, LOGIGIAN EL: The overdiagnosis of Lyme disease. JAMA (1993) 269:1812–1816.
   PubMed Web of Science ®Google Scholar
• SIGAL LH, PATELLA SJ: Lyme arthritis as the incorrect diagnosis in pediatric and adolescent fibromyalgia. Pediatrics (1992) 90:523–528.
   PubMed Web of Science ®Google Scholar
• MEEK JI, ROBERTS CL, SMITH EV, CARTTER ML: Underreporting of Lyme disease by Connecticut physicians, 1992. J. Public Health Manag. Piaci (1996) 2:61–65.
   PubMedGoogle Scholar
• LAUTIN A, MCNEIL EL, LIEGNER KB, STRICKER RB, SIGAL LH: Lyme disease controversy: use and misuse of language. Ann. Intern. Med. (2002) 137:775–777.
   PubMedGoogle Scholar
• •A broad overview of the Lyme disease controversy.
   Google Scholar
• BAKKEN LK, CASE KL, CALLISTER SM, BOURDEAU NJ, SCHELL RF: Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology. JAMA (1992) 268:891–895.
   PubMed Web of Science ®Google Scholar
• BROWN SL, HANSON SL, LANGONE JJ: Role of serology in the diagnosis of Lyme disease. JAMA (1999) 282:62-66. The FDA view of Lyme disease testing.
   Google Scholar
• MONTGOMERY RR, NATHANSON MH, MALAWISTA SE: The fate of Borrelia burgdorferi, the agent for Lyme disease, in mouse macrophages. Destruction, survival, recovery. J. Iminunol (1993) 150:909–915.
   PubMed Web of Science ®Google Scholar
• BOCKENSTEDT LK, MAO J, HODZIC E, BARTHOLD SW, FISH D: Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment. J. Infect. Dis. (2002) 186:1430–1437.
   PubMed Web of Science ®Google Scholar
• STRAUBINGER RK, SUMMERS BA, CHANG YF, APPEL MJ: Persistence of Borrelia burgdorferiin experimentally infected dogs after antibiotic treatment. Clin. Microbiol (1997) 35:111–116.
   Web of Science ®Google Scholar
• STRAUBINGER RK: PCR-based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-day postinfection period. I. Clin. Microbiol (2000) 38:2191–2199.
   PubMed Web of Science ®Google Scholar
• CADAVID D, O'NEILLT, SCHAEFER H, PACHNER AR: Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of Lyme disease. Lab. Invest. (2000) 80:1043–1054.
   PubMed Web of Science ®Google Scholar
• PREAC-MURSIC V, WEBER K, PFISTER HVV et al.: Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borrefiosis. Infection (1989) 17:355–359.
   PubMed Web of Science ®Google Scholar
• FREY M, JAULHAC B, PIEMONT Y et al.: Detection of Borrelia burgdorferi DNA in muscle of patients with chronic myalgia related to Lyme disease. Am. J. Med. (1998) 104:591–594.
   PubMed Web of Science ®Google Scholar
• •A tissue study of long-term infection in humans with Lyme disease.
   Google Scholar
• OKSI J, MARJAMAKI M, NIKOSKELAINEN J et al.: Borrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis. Ann. Med. (1999) 31:225–232.
   PubMed Web of Science ®Google Scholar
• BENACH JL, COLEMAN JL, HABICHT GS, MACDONALD A, GRUNWALDT E, GIRON JA: Serological evidence for simultaneous occurrences of Lyme disease and babesiosis. Infect. Dis. (1985) 152:473–477.
   Google Scholar
• MARCUS LC, STEERE AC, DURAY PH, ANDERSON AE, MAHONEY EB: Fatal pancarditis in a patient with coexistent Lyme disease and babesiosis. Demonstration of spirochetes in the myocardium. Ann. Intern. Med. (1985) 103:374–376.
   PubMed Web of Science ®Google Scholar
• NADELMAN RB, HOROWITZ HW, HSIEH TC et aL: Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis. N Eng]. I Med. (1997) 337:27–30.
   PubMed Web of Science ®Google Scholar
• DEMARTINO SJ, CARLYON JA, FIKRIG E: Coinfections with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis. N Engt I Med. (2001) 345:150–151.
   PubMed Web of Science ®Google Scholar
• KRAUSE PJ, MCKAY K, THOMPSON CA et al: Disease-specific diagnosis of coinfecting tickborne zoonoses: babesiosis, human granulocytic ehrlichiosis, and Lyme disease. Clin. Infect. Dis. (2002) 34:1184–1191.
   PubMed Web of Science ®Google Scholar
• STRICKER RB, HARRIS NS, YONG DC, WINGER EE: Clinical and seroepidemiologic characteristics of Babesia WA-1 coinfection in patients with Lyme disease in California. I Invest. Med. (2003) 51\(Suppl. 1):5145.
   Google Scholar
• •Co-infection with an emerging pathogen, Babesia WA-1, in Lyme disease patients.
   Google Scholar
• ESKOW E, RAO RV, MORDECHAI E: Concurrent infection of the central nervous system by Borrelia burgdorferi and Bartonella henselae: evidence for a novel tick-borne disease complex. Arch. Nemo]. (2001) 58:1357–1363.
   PubMed Web of Science ®Google Scholar
• •First description of tick transmission of Bartonella benselae.
   Google Scholar
• HARVEY WT, SAL VATO P: 'Lyme disease': ancient engine of an unrecognized borreliosis pandemic? Med. Hypotheses (2003) 60:742–759.
   PubMed Web of Science ®Google Scholar
• ••Excellent review of the Lyme diseasecontroversy.
   Google Scholar
• STRICKER RB, MOORE DH, WINGER EE: Clinical and immunologic evidence for transmission of Lyme disease through intimate human contact. (2003) (Abstract; submitted).
   Google Scholar
• PAVIA CS: Current and novel therapies forLyme disease. Expert Opin. Investig. Drugs (2003) 12:1003–1016.
   PubMed Web of Science ®Google Scholar
• ZORE A, RUZIC-SABLJIC E, MARASPIN V et al.: Sensitivity of culture and polymerase chain reaction for the etiologic diagnosis of erythema migrans. Wien. KIM. Wochenschr. (2002) 114:606–609.
   PubMed Web of Science ®Google Scholar
• LIVERIS D, WANG G, GIRAO G et al.: Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findings. .1. Clin. Microbiol (2002) 40:1249–1253.
   Google Scholar
• HICKS CB: Confronting the clinical uncertainty regarding syphilis. AIDS Clin. Care (2003) 15:64–65.
   PubMedGoogle Scholar
• STRICKER RB, PHILLIPS SE: Lyme disease without erythema migrans: Cause for concern? Am. I Med. (2003) 115(1):72–73.
   Google Scholar
• BRUCK DK, TALBOT ML, CLUSS RG, BOOTHBY JT: Ultrastructural characterization of the stages of spheroplast preparation of Borrelia burgdorferi .1. Microbial. Methods (1995) 23:219–228.
   Web of Science ®Google Scholar
• PREAC-MURSIC V, WANNER G, REINHARDT S, WILSKE B, BUSCH U, MARGET W: Formation and cultivation of Borrelia burgdorferispheroplast L-form variants. Infection (1996) 24:218–226.
   PubMed Web of Science ®Google Scholar
• ALBAN PS, JOHNSON PW, NELSON DR: Serum-starvation-induced changes in protein synthesis and morphology of Borrelia burgdorferi Microbiology(2000) 146\(Pt 1):119–127.
   Google Scholar
• BRORSON 0, BRORSON SH: A rapid method for generating cystic forms of Borrelia burgdorferi, and their reversal to mobile spirochetes. APMIS (1998) 106:1131–1141.
   PubMed Web of Science ®Google Scholar
• BRORSON 0, BRORSON SH: An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to metronidazole. APMIS (1999) 107:566–576.
   PubMed Web of Science ®Google Scholar
• KERSTEN A, POITSCHEK C, RAUCH S, ABERER E: Effects of penicillin, ceftriaxone, and doxycycline on the morphology of Borrelia burgdorferi Antimicrob. Agents Chemo. (1995) 39:1127–1133.
   PubMed Web of Science ®Google Scholar
• ABERER E, KOSZIK F, SILBERER M: Why is chronic Lyme borreliosis chronic? Clin. Infect. Dis. (1997) 25\(Suppl. 1):564–570.
   Google Scholar
• SCHOELER GB, WIKEL SK: Modulationof host immunity by haematophagous arthropods. Ann. Bop. Med. Parasitol. (2001) 95:755–771.
   PubMed Web of Science ®Google Scholar
• HANNIER S, LIVERSIDGE J, STERNBERG JM, BOWMAN AS: Ixodes ricinus tick salivary gland extract inhibits IL-10 secretion and CD69 expression by mitogen-stimulated murine splenocytes and induces hyporesponsiveness in B lymphocytes. Parasite haamunol (2003) 25:27–37.
   PubMed Web of Science ®Google Scholar
• RHEN M, ERIKSSON S, CLEMENTS M, BERGSTROM S, NORMARK SJ: The basis of persistent bacterial infections. Trends Microbiol (2003) 11:80–86.
   PubMed Web of Science ®Google Scholar
• •An overview of mechanisms of chronic bacterial infection comparing Borrelia and Mycobacteria.
   Google Scholar
• LIANG FT, JACOBS MB, BOWERS LC, PHILIPP MT: An immune evasion mechanism for spirochetal persistence in Lyme borreliosis. Exp. Med. (2002) 195:415–422.
   PubMed Web of Science ®Google Scholar
• •Description of an immune evasion mechanism that leads to persistence of B. burgdorferi infection.
   Google Scholar
• GUNER ES: Complement evasion by the Lyme disease spirochete Borrelia burgdorferi grown in host-derived tissue co-cultures: role of fibronectin in complement-resistance. Experientia (1996) 52:364–372.
   PubMedGoogle Scholar
• PORCELLA SF, SCHWAN TG: Borrelia burgdorferi and Treponema pallidum: a comparison of functional genomics, environmental adaptations, and pathogenic mechanisms. Clin. Invest. (2001) 107:651–656.
   Google Scholar
• ••An excellent description of the complexityof B. burgdorferi compared to 7: palliclurn.
   Google Scholar
• MAY, STURROCK A, WEIS JJ: Intracellular localization of Borrelia burgdorferi within human endothelial cells. Infect. hnmun. (1991) 59:671–678.
   PubMed Web of Science ®Google Scholar
• KLEMPNER MS, NORING R, ROGERS RA: Invasion of human skin fibroblasts by the Lyme disease spirochete, Borrelia burgdorferi Infect. Dis. (1993) 167:1074–1081.
   Google Scholar
• GIRSCHICK HJ, HUPPERTZ HI, RUSSMANN H, KRENN V, KARCH H: Intracellular persistence of Borrelia burgdorferiin human synovial cells. Rheumatol hat (1996) 16:125–130.
   Web of Science ®Google Scholar
• LINDER S, HEIMERL C, FINGERLE V, AEPFELBACHER M, WILSKE B: Coiling phagocytosis of Borrelia burgdorferi by primary human macrophages is controlled by CDC42Hs and Racl and involves recruitment of Wiskott-Aldrich syndrome protein and Arp2/3 complex. Infect. Inman. (2001) 69:1739–1746.
   PubMed Web of Science ®Google Scholar
• GEORGILIS K, PEACOCKE M, KLEMPNER MS: Fibroblasts protect the Lyme disease spirochete, Borrelia burgdorferl from ceftriaxone in vitro. .1. Infect. Dis. (1992) 166:440–444.
   PubMed Web of Science ®Google Scholar
• •Demonstration of functional resistance of intracellular B. burgdorferi to ceftriaxone.
   Google Scholar
• BROUQUI P, BADIAGA S, RAOULT D: Eukaryotic cells protect Borrelia burgdorferi from the action of penicillin and ceftriaxone but not from the action of doxycycline and erythromycin. Antimicrob. Agents Chemother. (1996) 40:1552–1554.
   PubMed Web of Science ®Google Scholar
• THOMAS V, ANGUITA J, BARTHOLD SW, FIKRIG E: Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis. Infect. Inman. (2001) 69:3359–3371.
   PubMed Web of Science ®Google Scholar
• ZEIDNER NS, DOLAN MC, MASSUNG R, PIESMAN J, FISH D: Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis suppresses IL-2 and IFN gamma production and promotes an IL-4 response in C3H/HeJ mice. Parasite ImmunoL (2000) 22:581–588.
   PubMed Web of Science ®Google Scholar
• MORO MH, ZEGARRA-MORO OL, BJORNSSON J et al.: Increased arthritis severity in mice coinfected with Borrelia burgdorferi and Babesia micron: J. Infect. Dis. (2002) 186:428–431.
   Google Scholar
• KRAUSE PJ, TELFORD SR 3rd, SPIELMAN A et al.: Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. JA/VIA (1996) 275:1657–1660.
   Google Scholar
• •Influence of coinfection on Lyme disease severity and duration.
   Google Scholar
• NADELMAN RB, WORMSER GP: Single-dose doxycycline for the prevention of Lyme disease. N Engl. J. Med. (2001) 345:1349–1350.
   Google Scholar
• BURRASCANO JJ: Lyme disease. In: Conn's Current Therapy WB Saunders Company, Philadelphia, PA, USA (1997):140–143.
   Google Scholar
• ••An important review of Lyme diseasediagnosis and treatment.
   Google Scholar
• LIEGNER KB, KOCHEVAR J: Guidelines for the clinical diagnosis of Lyme disease. Ann. Intern. Med. (1998) 129:422–423.
   PubMedGoogle Scholar
• BRANSFIELD R, BRAND S, SHERR V: Treatment of patients with persistent symptoms and a history of Lyme disease. N. Engl. J. Med. (2001) 345:1424–1425.
   PubMedGoogle Scholar
• •An abbreviated critique of [58], the flawed study of long-term' antibiotic therapy for Lyme disease.
   Google Scholar
• LAWRENCE C, LIPTON RB, LOWY FD, COYLE PK: Seronegative chronic relapsing neuroborreliosis. Eur. NeuroL (1995) 35:113–117.
   PubMed Web of Science ®Google Scholar
• FRASER DD, KONG LI, MILLER FVV: Molecular detection of persistent Borrelia burgdorferiin a man with dermatomyositis. Gin. Exp. Rheumatol. (1992) 10:387–390.
   PubMed Web of Science ®Google Scholar
• KLEMPNER MS, HU LT, EVANS J et al.: Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N EngL I Med. (2001) 345:85–92.
   PubMed Web of Science ®Google Scholar
• WORMSER GP, RAMANATHAN R, NOWAKOWSKI J et al.: Duration of antibiotic therapy for early lyme disease. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. (2003) 138:697–704.
   PubMed Web of Science ®Google Scholar
• STRICKER RB, WINGER EE: Decreased CD57 lymphocyte subset in patients with chronic Lyme disease. Immunol Lett. (2001) 76:43–48.
   PubMed Web of Science ®Google Scholar
• •Initial description of an immunological defect in chronic Lyme disease.
   Google Scholar
• STRICKER RB, BURRASCANO J, WINGER EE: Longterm decrease in the CD57 lymphocyte subset in a patient with chronic Lyme disease. Ann. Agile. Environ. Med. (2002) 9:111–113.
   PubMed Web of Science ®Google Scholar
• STRICKER RB, WINGER EE: Normalization of the CD57 natural killer cell subset associated with prolonged antibiotic therapy in patients with chronic Lyme disease. Clin. Immunol (2002) 103:S117–S118.
   Web of Science ®Google Scholar
• SMALL PM, FUJIWARA PI: Management of tuberculosis in the United States. N EngL J. Med. (2001)345:189–200.
   PubMed Web of Science ®Google Scholar
• SHAW IN, NATRAJAN MM, RAO GS, JESUDASAN K, CHRISTIAN M, KAVITHA M: Long-term follow up of multibacillary leprosy patients with high BI treated with WHO/MDT regimen for a fixed duration of two years. Int. j Lepc Other Mycobact. Dis. (2000) 68:405–409.
   PubMedGoogle Scholar
• GOTO M: Chemotherapy of leprosy: theoretical basis of new guideline in Japan. Nihon Hansenbyo Cakkai Zasshi (2001) 70:151–155.
   PubMedGoogle Scholar
• www.geocities.com/HotSprings/Oasis/ 6455/1yme-links.html Lots of links on Lyme disease - over 12,000 categorised links on Lyme disease (2001).
   Google Scholar
• ••The most extensive collection of Lymedisease references in existence.
   Google Scholar
• http://www.ilads.org/stricker.htm PHILLIPS SE, BRANSFIELD R, SHERR VT et al.: Evaluation of antibiotic treatment in patients with persistent symptoms of Lyme disease: an ILADS position paper (2003).
   Google Scholar
• ••A comprehensive critique of [58], the flawed study of long-term' antibiotic therapy for Lyme disease.
   Google Scholar